Article Text

other Versions


Contribution of inflammation to the pathology of Idiopathic Pulmonary Arterial Hypertension in children.
  1. Susan M Hall (s.hall{at}
  1. UCL Institute of Child Health, United Kingdom
    1. Paul Brogan (p.brogan{at}
    1. UCL Institute of Child Health, United Kingdom
      1. Sheila G Haworth (s.haworth{at}
      1. Great Ormond Street Hospital for Children NHS Trust, United Kingdom
        1. Nigel Klein (n.klein{at}
        1. UCL Institute of Child Health, United Kingdom


          Idiopathic Pulmonary Arterial Hypertension (IPAH) is an incurable disease of multifactorial origin. Inflammation is frequently observed in IPAH, but its role in the pathobiology is unclear. In this study we characterised and compared the distribution, nature and number of inflammatory cells in peri-arterial infiltrates in lungs of children with IPAH, pulmonary arterial hypertension associated with congenital heart disease (APAH), and in normal lung tissue, using immunohistochemistry. The influence of treatment with combined prostacyclin and endothelin receptor blockers was also studied. In children with IPAH, both treated and untreated, but not in APAH or normal children, extensive peri-arterial infiltrates were present comprising macrophages and T-lymphocytes with S100A4 and bone morphogenetic protein receptor type 2 (BMPR2) positive cells. Although rarely co-expressing macrophage specific antigens, BMPR2 positive cells were frequently closely associated with macrophages and lymphocytes. They were more abundant around peripheral arteries of children with IPAH than in APAH or normal lungs (respectively 15.1±3.5; 2.3±0.9; 2.3±0.9 cells/mm external elastic lamina; p<0.01 for IPAH versus APAH or normal lungs). Prostacyclin with endothelin receptor blockade resulted in a significant reduction in endothelial cell activation as indicated by HLA-DR expression (treated 17% versus untreated 100%, p<0.002). This study shows that pulmonary inflammation is present in the lungs of children with IPAH. This may indicate a role for inflammation in the pathobiology of IPAH and provide the rationale for novel therapeutic intervention.

          Statistics from

          Request permissions

          If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.